Bruker Corporation's stock experienced a significant intraday plummet of 14.52% on Thursday, following the release of its fourth-quarter financial results.

The sharp decline came after the medical equipment maker reported adjusted earnings per share of $0.59 for the quarter, missing the analyst consensus estimate of $0.65. This represents a 9.09% earnings miss and a 22.37% decrease compared to earnings of $0.76 per share from the same period last year.

While the company's quarterly sales of $977.2 million surpassed analyst expectations, the substantial profit shortfall and significant year-over-year earnings decline appear to have driven the negative investor sentiment during the trading session.